US Patent 7482344 Tricyclic steroid hormone nuclear receptor modulators
Patent 7482344 was granted and assigned to Eli Lilly and Company on January, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7482344 Tricyclic steroid hormone nuclear receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
